Opens in a new tab
Join Us

Innovative Treatment Modalities

Elevating treatment pathways in recurrent UTI care

Innovative treatment modalities are essential in the management of chronic, recurrent and embedded urinary tract infections. Standard short-course antibiotic approaches are often insufficient where biofilm persistence, epithelial dysfunction or immune factors contribute to recurrence.

This standard defines how accredited centres integrate advanced therapeutic strategies into structured clinical pathways. The objective is targeted intervention, symptom resolution and long-term recurrence reduction.

The UTI Institute Accreditation recognises clinics that adopt evidence-led, multi-modal treatment approaches within accountable governance frameworks.

Apply for Accreditation

Why this matters

Recurrent UTI management frequently becomes cyclical when treatment is limited to repeated empirical antibiotic courses. Without addressing underlying inflammatory, structural or microbiological complexity, relapse risk remains high.

Emerging research into biofilm behaviour, bladder lining integrity and host response highlights the need for broader therapeutic strategies in selected patients.

Accreditation formalises the integration of innovative modalities within structured, evidence-based practice.

Structured capability across three interconnected domains

Accredited centres must demonstrate each domain within documented, governed clinical pathways.
Advanced Oral Therapeutic Protocols

Clinics must demonstrate clearly defined oral treatment strategies for chronic and embedded infections. Protocols should reflect contemporary understanding of persistence mechanisms and resistance patterns, balancing efficacy with stewardship.

Intravesical and Bladder Lining Therapies

Accredited centres should demonstrate competence in the use of intravesical treatments where clinically indicated, including bladder instillation therapies designed to support epithelial repair or deliver targeted antimicrobial agents.

Integrated Multi-Modal Pathways

Innovative treatment should not occur in isolation. Accredited clinics must demonstrate how oral therapies, intravesical strategies and diagnostic findings are integrated within a coordinated care plan.

Apply for Accreditation

Indicators of advanced practice

Clinics operating within this standard typically demonstrate:
Defined treatment algorithms for recurrent and chronic UTI
Reduced reliance on repetitive short-course antibiotics
Integration of intravesical or bladder-directed therapies where indicated
Clear linkage between diagnostics and therapeutic selection
Ongoing audit of treatment outcomes and recurrence rates

Who this standard is designed for

This accreditation pillar is intended for specialist clinics managing recurrent, persistent or treatment-resistant UTIs requiring advanced therapeutic intervention.

It is suited to centres offering structured, multi-modal treatment pathways.

It is not designed for routine, uncomplicated infection management.

View Accredited Members

Advancing the Global Standard

The UTI Institute Accreditation ensures advanced practice is applied systematically, responsibly and within defined governance frameworks. If your clinic reflects these principles, we invite you to formalise that expertise.

Urinary tract infections are among the most prevalent infections globally, yet they remain critically underserved. For too long, patients have faced outdated diagnostics, a severe lack of research funding, and a reliance on oral antibiotics that disrupts the gut biome and fuels antimicrobial resistance. This status quo is unsustainable.

The UTI Institute was founded to change this paradigm. We aim to be the definitive hub for excellence, driving collaborative research, offering a trusted network of expert clinics, and delivering advanced, streamlined care. We are committed to leading the way in driving innovation, challenging the status quo, and ultimately transforming UTI care for patients globally.

Bob Yang – Director of the UTI Institute